palladium has been researched along with Invasiveness, Neoplasm in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, W; Finger, PT; Semenova, E | 1 |
Chamberlain, D; Cunningham, J; Ding, W; Lee, J; Tay, J; Yang, L | 1 |
Barman, M; Finger, PT; Milman, T | 1 |
Adamovich, E; Butler, WM; Galbreath, RW; Merrick, GS; Wallner, KE | 1 |
Cash, J; Dattoli, M; Sorace, R; True, L; Wallner, K | 2 |
Able, AM; Artiles, C; Banks, SJ; Blair, DN; Clarke, DH; Hindle, WV; Houk, RR; Klousia, JW; Lissy, JM; Miller, M; Sheridan, MJ; Wiederhorn, AR | 1 |
7 other study(ies) available for palladium and Invasiveness, Neoplasm
Article | Year |
---|---|
Squamous Cell Carcinoma Invading a Transplanted Cornea: Eye- and Vision-Sparing Palladium-103 Plaque Radiation Therapy for a Functionally Monocular Patient.
Topics: Brachytherapy; Carcinoma, Squamous Cell; Cornea; Eye Neoplasms; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Neoplasm Invasiveness; Palladium; Radioisotopes; Treatment Outcome; Uveal Neoplasms | 2018 |
Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Topics: Aged; Analysis of Variance; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Time Factors | 2012 |
Scleral patch grafts in the management of uveal and ocular surface tumors.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Cryotherapy; Female; Free Tissue Flaps; Humans; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Nevus, Pigmented; Ophthalmologic Surgical Procedures; Palladium; Radiation Injuries; Radioisotopes; Retrospective Studies; Sclera; Scleral Diseases; Transplantation, Homologous; Uveal Neoplasms; Visual Acuity | 2012 |
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Topics: Adenocarcinoma; Adult; Brachytherapy; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Life Tables; Male; Middle Aged; Neoplasm Invasiveness; Palladium; Proportional Hazards Models; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Radiotherapy, High-Energy; Risk; Treatment Outcome | 2004 |
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Topics: Aged; Biopsy, Needle; Brachytherapy; Carcinoma; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Probability; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Risk Assessment; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome | 2007 |
The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants.
Topics: Brachytherapy; Combined Modality Therapy; Follow-Up Studies; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Palladium; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Regression Analysis | 2002 |